| Year |
Citation |
Score |
| 2023 |
Siegel JB, Nasarre P, Hsu L, Mukherjee R, Gormley M, Richardson B, Khan I, Morningstar JE, Hilliard E, O'Bryan JP, Helke KL, Spruill L, Dolloff NG, Klauber-DeMore N. Secreted frizzled related-protein 2 is prognostic for human pancreatic cancer patient survival and is associated with fibrosis. Cancer Biomarkers : Section a of Disease Markers. PMID 37955079 DOI: 10.3233/CBM-220044 |
0.339 |
|
| 2020 |
Dimou A, Nasarre C, Peterson YK, Pagano R, Gooz M, Nasarre P, Drabkin HA, Armeson KE, Gibney BC, Gemmill RM, Denlinger CE. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. PMID 32653291 DOI: 10.1016/J.Jtcvs.2020.03.166 |
0.452 |
|
| 2020 |
Wofford WO, Mukherjee R, Siegel J, Garcia D, Hilliard E, Nasarre P, Klauber-DeMore N, Javid M. MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.032 |
0.371 |
|
| 2020 |
Nasarre C, Peterson YK, Nasarre P, Dimou A, Armeson KE, Drabkin HA, Demore N, Denlinger CE, Gemmill RM. Abstract 2994: Inhibition of the NRP2b:GSK3β binding interaction with peptides and macrocycles exerts anticancer effects in lung cancer Cancer Research. 80: 2994-2994. DOI: 10.1158/1538-7445.Am2020-2994 |
0.461 |
|
| 2019 |
Garcia D, Nasarre P, Bonilla IV, Hilliard E, Peterson YK, Spruill L, Broome AM, Hill EG, Yustein JT, Mehrotra S, Klauber-DeMore N. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Annals of Surgical Oncology. PMID 31515721 DOI: 10.1245/S10434-019-07800-2 |
0.419 |
|
| 2019 |
Chakraborty P, Chatterjee S, Kesarwani P, Thyagarajan K, Iamsawat S, Dalheim A, Nguyen H, Selvam SP, Nasarre P, Scurti G, Hardiman G, Maulik N, Ball LE, Gangaraju V, Rubinstein MP, et al. Thioredoxin-1 improves the immuno-metabolic phenotype of anti-tumor T cells. The Journal of Biological Chemistry. PMID 30971427 DOI: 10.1074/Jbc.Ra118.006753 |
0.407 |
|
| 2019 |
Dimou A, Nasarre C, Gooz M, Pagano R, Peterson Y, Armeson K, Drabkin HA, Nasarre P, Denlinger CE, Gemmill RM. Abstract 2624: NRP2b promotes migration, drug resistance and AKT activation in lung cancers by recruiting GSK3â to phosphorylate and destabilize PTEN Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2624 |
0.466 |
|
| 2018 |
Nasarre P, Bonilla IV, Metcalf JS, Hilliard EG, Klauber-DeMore N. TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma. Melanoma Research. PMID 29553967 DOI: 10.1097/Cmr.0000000000000440 |
0.48 |
|
| 2017 |
Peterson YK, Nasarre P, Bonilla IV, Hilliard E, Samples J, Morinelli TA, Hill EG, Klauber-DeMore N. Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis. Angiogenesis. PMID 28840375 DOI: 10.1007/S10456-017-9574-5 |
0.453 |
|
| 2017 |
Gemmill RM, Nasarre P, Nair-Menon J, Cappuzzo F, Landi L, D'Incecco A, Uramoto H, Yoshida T, Haura EB, Armeson K, Drabkin HA. The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer. Science Signaling. 10. PMID 28096505 DOI: 10.1126/Scisignal.Aag0528 |
0.579 |
|
| 2017 |
Dimou A, Nasarre P, Nair-Menon J, Cappuzzo F, Landi L, D'Incecco A, Uramato H, Yoshida T, Haura E, Gooz M, Armeson K, Gemmill R, Drabkin H. Abstract 4853: NRP2b, a unique isoform of NRP2, promotes aggressive lung cancer phenotypes Cancer Research. 77: 4853-4853. DOI: 10.1158/1538-7445.Am2017-4853 |
0.531 |
|
| 2016 |
Roche J, Nasarre P, Gemmill R, Baldys A, Pontis J, Korch C, Guilhot J, Ait-Si-Ali S, Drabkin H. Erratum: Roche, J. et al. Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers, 2013, 5, 334-356. Cancers. 8. PMID 27983677 DOI: 10.3390/Cancers8120114 |
0.698 |
|
| 2016 |
Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Muñoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. Plos One. 11: e0147344. PMID 26789630 DOI: 10.1371/Journal.Pone.0147344 |
0.704 |
|
| 2014 |
Nasarre P, Gemmill RM, Drabkin HA. The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. Oncotargets and Therapy. 7: 1663-87. PMID 25285016 DOI: 10.2147/Ott.S37744 |
0.512 |
|
| 2013 |
Roche J, Nasarre P, Gemmill R, Baldys A, Pontis J, Korch C, Guilhot J, Ait-Si-Ali S, Drabkin H. Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers. 5: 334-56. PMID 24216980 DOI: 10.3390/Cancers5020334 |
0.761 |
|
| 2013 |
Nasarre P, Gemmill RM, Potiron VA, Roche J, Lu X, Barón AE, Korch C, Garrett-Mayer E, Lagana A, Howe PH, Drabkin HA. Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition. Cancer Research. 73: 7111-21. PMID 24121493 DOI: 10.1158/0008-5472.Can-13-1755 |
0.799 |
|
| 2012 |
Nasarre P, Roche J, Potiron VA, Nair-Menon J, Gemmill RM, Drabkin HA. Abstract 2416: Neuropilin-2 is upregulated during EMT in lung cancer Cancer Research. 72: 2416-2416. DOI: 10.1158/1538-7445.Am2012-2416 |
0.799 |
|
| 2011 |
Testori J, Schweighofer B, Helfrich I, Sturtzel C, Lipnik K, Gesierich S, Nasarre P, Hofer-Warbinek R, Bilban M, Augustin HG, Hofer E. The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells. Blood. 117: 2735-44. PMID 21224470 DOI: 10.1182/Blood-2010-07-293209 |
0.443 |
|
| 2011 |
Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA. ZEB1-responsive genes in non-small cell lung cancer. Cancer Letters. 300: 66-78. PMID 20980099 DOI: 10.1016/J.Canlet.2010.09.007 |
0.798 |
|
| 2010 |
Nasarre P, Potiron V, Drabkin H, Roche J. Guidance molecules in lung cancer. Cell Adhesion & Migration. 4: 130-45. PMID 20139699 DOI: 10.4161/Cam.4.1.10882 |
0.796 |
|
| 2010 |
Roche J, Nasarre P, Potiron V, Nair-Menon J, Gemmill R, Drabkin H. Abstract 4969: Neuropilin-2 is downregulated by Snail during EMT in lung cancer Cancer Research. 70: 4969-4969. DOI: 10.1158/1538-7445.Am10-4969 |
0.822 |
|
| 2009 |
Nasarre P, Thomas M, Kruse K, Helfrich I, Wolter V, Deppermann C, Schadendorf D, Thurston G, Fiedler U, Augustin HG. Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth. Cancer Research. 69: 1324-33. PMID 19208839 DOI: 10.1158/0008-5472.Can-08-3030 |
0.395 |
|
| 2007 |
Potiron VA, Sharma G, Nasarre P, Clarhaut JA, Augustin HG, Gemmill RM, Roche J, Drabkin HA. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Research. 67: 8708-15. PMID 17875711 DOI: 10.1158/0008-5472.Can-06-3612 |
0.769 |
|
| 2007 |
Potiron V, Nasarre P, Roche J, Healy C, Boumsell L. Semaphorin signaling in the immune system. Advances in Experimental Medicine and Biology. 600: 132-44. PMID 17607952 DOI: 10.1007/978-0-387-70956-7_11 |
0.743 |
|
| 2005 |
Nasarre P, Constantin B, Drabkin HA, Roche J. [Semaphorins and cancers : an up 'dating']. Medecine Sciences : M/S. 21: 641-7. PMID 15985208 DOI: 10.1051/Medsci/2005216-7641 |
0.774 |
|
| 2005 |
Kusy S, Nasarre P, Chan D, Potiron V, Meyronet D, Gemmill RM, Constantin B, Drabkin HA, Roche J. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia (New York, N.Y.). 7: 457-65. PMID 15967098 DOI: 10.1593/Neo.04721 |
0.786 |
|
| 2005 |
Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, Roche J. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia (New York, N.Y.). 7: 180-9. PMID 15802023 DOI: 10.1593/Neo.04481 |
0.801 |
|
| 2003 |
Nasarre P, Constantin B, Rouhaud L, Harnois T, Raymond G, Drabkin HA, Bourmeyster N, Roche J. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia (New York, N.Y.). 5: 83-92. PMID 12659673 DOI: 10.1016/S1476-5586(03)80020-9 |
0.784 |
|
| Show low-probability matches. |